Violet
Viola odorata in Professional Aromatherapy and Perfumery
Botanical name: Viola odorata L.
Family: Violaceae
Common name: Sweet violet
Aromatic material used in practice: most commonly violet leaf absolute / leaf extract, rather than a conventional steam-distilled essential oil. In trade and formulation documents, violet leaf materials are identified as Viola odorata leaf extract and are classified primarily for perfumery and aromatic use. Research on violet leaf absolutes also confirms that the commercially important fragrant material is obtained from the leaves.
1. Material identity and extraction
From a professional aromatherapy standpoint, violet must be handled as a specialty aromatic extract. The most relevant material is the leaf absolute, typically produced through solvent-based extraction and alcohol processing rather than standard steam distillation. Commercial safety data sheets list it as Viola odorata leaf extract, often with denatured alcohol present in the finished material. Analytical and fragrance literature describes violet leaf absolute as a rare, high-value natural extract used in the flavor and fragrance industry, with production centered historically in places such as France and Egypt.
2. Organoleptic profile
Professionally, violet leaf is best classified as a green-leaf aromatic rather than a lush floral note. Even when derived from the violet plant, the leaf extract is valued for its cool green, watery, crushed-leaf, and cucumber-like tonalities more than for a sweet “purple flower” effect. Published work on violet leaf absolutes also shows that origin materially affects olfactory profile, with French and Egyptian absolutes demonstrating perceptible differences in both top and heart notes.
3. Chemical profile and variability
A key professional issue with violet is chemical inconsistency across commercial materials. A 2023 study evaluating three commercially available Viola odorata oils found substantial variability between samples, with differing dominant constituents across suppliers. Reported major compounds included phenethyl alcohol, isopropyl myristate, methyl ester derivatives of 2-nonynoic acid, α-terpineol, α-cetone, and benzyl acetate. This degree of variability means violet materials should not be treated as chemically interchangeable across brands or batches.
Older compositional work on V. odorata leaf oil also found a very different profile again, underscoring the point that extraction method, source, and chemotype strongly affect the finished aromatic material. In that study, 25 compounds represented 92.77% of the analyzed oil, with butyl-2-ethylhexylphthalate and a benzofuranone derivative reported as dominant in that specific sample.
4. Evidence base for aromatherapy use
The evidence base for violet in aromatherapy is limited and must be interpreted carefully. Although Viola odorata is often recommended in aromatherapeutic literature for respiratory, urinary, and skin infections, a 2023 study concluded that commercially available violet oil samples showed overall poor antimicrobial activity when tested alone. Some synergistic effects were observed when violet was combined with other essential oils, but that does not support strong stand-alone antimicrobial claims for violet itself.
This caution is reinforced by broader phytochemical review literature: many of the antioxidant, anti-inflammatory, and medicinal findings associated with Viola odorata concern nonvolatile extracts of the plant, not necessarily the aromatic leaf absolute used in professional perfumery/aromatherapy. One systematic review explicitly noted that antioxidant activity was not observed in the essential oil, while various plant extracts showed low to moderate activity.
5. Clinical relevance
There is some human clinical literature involving violet preparations, especially in traditional Iranian medicine, but it should not be overstated in an aromatherapy dossier. One clinical study on chronic insomnia used intranasal violet oil drops nightly for one month and reported improved sleep scores with no serious adverse events. Separate published trials also investigated sweet violet flower oil in allergic rhinitis. However, these studies involve specific traditional preparations and routes of administration, not standard diffuser use or routine topical aromatherapy practice. Their findings are therefore relevant as signals of interest, but not direct validation of general aromatherapy claims.
6. Safety profile
Professionally, violet leaf absolute should be treated as a potent aromatic extract with irritation and sensitization potential. A current EU-format safety data sheet classifies violet leaf absolute as a flammable liquid, a skin irritant, and a skin sensitizer, with hazard statements including H315 (causes skin irritation) and H317 (may cause an allergic skin reaction). The same SDS also notes environmental hazard concerns and identifies linalool as a listed allergen at low concentration.
A separate supplier IFRA statement reports that violet leaf absolute is not specifically restricted as such under the cited IFRA standard set, but that does not remove the formulator’s responsibility to assess the safety of the finished product. In practice, violet should therefore be used conservatively, well diluted, patch tested where appropriate and evaluated in the context of the complete formula rather than assumed to be inherently gentle simply because of its soft odor profile.
7. Professional aromatic applications
In professional aromatic work, violet is best positioned as a refining and atmospheric ingredient rather than a primary therapeutic essential oil. Its strongest value lies in:
Because of its rarity, potency, and variable chemistry, violet is generally better suited to advanced blending than to beginner aromatherapy use. The material performs especially well in trace to low percentages where it can shape the character of a formula without dominating it. This positioning is consistent with the fragrance literature describing violet leaf absolute as a valuable, origin-sensitive perfumery material with highly distinctive odor-active markers.
8. Professional conclusion
From a scientific and professional aromatherapy perspective, Viola odorata is best understood as a specialty aromatic extract with high olfactory value and modest evidence for broad therapeutic claims. Its principal importance lies in perfumery-grade green nuance, emotional atmosphere, and formulation elegance. The current literature supports caution regarding overstated antimicrobial or medical claims, highlights major commercial variability, and indicates that much of the plant’s medicinal reputation comes from extracts that are not equivalent to the aromatic material used in perfumery and classical aromatherapy.
For professional use, violet should be positioned as an advanced aromatic modifier and subtle psycho-olfactory agent, not as a first-line therapeutic essential oil
Botanical name: Viola odorata L.
Family: Violaceae
Common name: Sweet violet
Aromatic material used in practice: most commonly violet leaf absolute / leaf extract, rather than a conventional steam-distilled essential oil. In trade and formulation documents, violet leaf materials are identified as Viola odorata leaf extract and are classified primarily for perfumery and aromatic use. Research on violet leaf absolutes also confirms that the commercially important fragrant material is obtained from the leaves.
1. Material identity and extraction
From a professional aromatherapy standpoint, violet must be handled as a specialty aromatic extract. The most relevant material is the leaf absolute, typically produced through solvent-based extraction and alcohol processing rather than standard steam distillation. Commercial safety data sheets list it as Viola odorata leaf extract, often with denatured alcohol present in the finished material. Analytical and fragrance literature describes violet leaf absolute as a rare, high-value natural extract used in the flavor and fragrance industry, with production centered historically in places such as France and Egypt.
2. Organoleptic profile
Professionally, violet leaf is best classified as a green-leaf aromatic rather than a lush floral note. Even when derived from the violet plant, the leaf extract is valued for its cool green, watery, crushed-leaf, and cucumber-like tonalities more than for a sweet “purple flower” effect. Published work on violet leaf absolutes also shows that origin materially affects olfactory profile, with French and Egyptian absolutes demonstrating perceptible differences in both top and heart notes.
3. Chemical profile and variability
A key professional issue with violet is chemical inconsistency across commercial materials. A 2023 study evaluating three commercially available Viola odorata oils found substantial variability between samples, with differing dominant constituents across suppliers. Reported major compounds included phenethyl alcohol, isopropyl myristate, methyl ester derivatives of 2-nonynoic acid, α-terpineol, α-cetone, and benzyl acetate. This degree of variability means violet materials should not be treated as chemically interchangeable across brands or batches.
Older compositional work on V. odorata leaf oil also found a very different profile again, underscoring the point that extraction method, source, and chemotype strongly affect the finished aromatic material. In that study, 25 compounds represented 92.77% of the analyzed oil, with butyl-2-ethylhexylphthalate and a benzofuranone derivative reported as dominant in that specific sample.
4. Evidence base for aromatherapy use
The evidence base for violet in aromatherapy is limited and must be interpreted carefully. Although Viola odorata is often recommended in aromatherapeutic literature for respiratory, urinary, and skin infections, a 2023 study concluded that commercially available violet oil samples showed overall poor antimicrobial activity when tested alone. Some synergistic effects were observed when violet was combined with other essential oils, but that does not support strong stand-alone antimicrobial claims for violet itself.
This caution is reinforced by broader phytochemical review literature: many of the antioxidant, anti-inflammatory, and medicinal findings associated with Viola odorata concern nonvolatile extracts of the plant, not necessarily the aromatic leaf absolute used in professional perfumery/aromatherapy. One systematic review explicitly noted that antioxidant activity was not observed in the essential oil, while various plant extracts showed low to moderate activity.
5. Clinical relevance
There is some human clinical literature involving violet preparations, especially in traditional Iranian medicine, but it should not be overstated in an aromatherapy dossier. One clinical study on chronic insomnia used intranasal violet oil drops nightly for one month and reported improved sleep scores with no serious adverse events. Separate published trials also investigated sweet violet flower oil in allergic rhinitis. However, these studies involve specific traditional preparations and routes of administration, not standard diffuser use or routine topical aromatherapy practice. Their findings are therefore relevant as signals of interest, but not direct validation of general aromatherapy claims.
6. Safety profile
Professionally, violet leaf absolute should be treated as a potent aromatic extract with irritation and sensitization potential. A current EU-format safety data sheet classifies violet leaf absolute as a flammable liquid, a skin irritant, and a skin sensitizer, with hazard statements including H315 (causes skin irritation) and H317 (may cause an allergic skin reaction). The same SDS also notes environmental hazard concerns and identifies linalool as a listed allergen at low concentration.
A separate supplier IFRA statement reports that violet leaf absolute is not specifically restricted as such under the cited IFRA standard set, but that does not remove the formulator’s responsibility to assess the safety of the finished product. In practice, violet should therefore be used conservatively, well diluted, patch tested where appropriate and evaluated in the context of the complete formula rather than assumed to be inherently gentle simply because of its soft odor profile.
7. Professional aromatic applications
In professional aromatic work, violet is best positioned as a refining and atmospheric ingredient rather than a primary therapeutic essential oil. Its strongest value lies in:
- green-leaf accords
- nervous-system support blends where subtlety is desired rather than strong sedation claims
- elegant floral-green compositions
- formulas intended to create emotional quiet, restraint, and soft diffusion rather than overt sweetness or intensity
Because of its rarity, potency, and variable chemistry, violet is generally better suited to advanced blending than to beginner aromatherapy use. The material performs especially well in trace to low percentages where it can shape the character of a formula without dominating it. This positioning is consistent with the fragrance literature describing violet leaf absolute as a valuable, origin-sensitive perfumery material with highly distinctive odor-active markers.
8. Professional conclusion
From a scientific and professional aromatherapy perspective, Viola odorata is best understood as a specialty aromatic extract with high olfactory value and modest evidence for broad therapeutic claims. Its principal importance lies in perfumery-grade green nuance, emotional atmosphere, and formulation elegance. The current literature supports caution regarding overstated antimicrobial or medical claims, highlights major commercial variability, and indicates that much of the plant’s medicinal reputation comes from extracts that are not equivalent to the aromatic material used in perfumery and classical aromatherapy.
For professional use, violet should be positioned as an advanced aromatic modifier and subtle psycho-olfactory agent, not as a first-line therapeutic essential oil
Chemical Analyses and Clinical Trials
Viola odorata for Aromatherapy and Professional Botanical Use1. Chemical analyses
The analytical literature on Viola odorata shows that “violet” is not a chemically uniform aromatic material. Composition varies substantially according to plant part, extraction method, origin, and likely adulteration status. This is especially important in professional aromatherapy, because commercial “violet oil” or “violet leaf” materials should not be assumed to be interchangeable across suppliers.
A 2012 GC–MS study on V. odorata leaves from central Iran, obtained by a hydro-distillation/solvent-extraction approach, identified 25 compounds representing 92.77% of the analyzed oil. In that sample, the dominant constituents were reported as butyl-2-ethylhexylphthalate (30.10%) and 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-2(4H)-benzofuranone (12.03%). This profile differs markedly from later studies, underscoring the instability of the chemical profile across preparations.
A more detailed 2014 study on violet leaf absolutes used HS-SPME GC/MS together with GC-O/MS and found a much broader volatile picture. The authors identified 70 compounds, of which 61 had not previously been reported for this species. They also demonstrated clear geographic variation between French and Egyptian materials. French-origin samples showed markers such as ethyl hexanoate and (2E,6Z)-nona-2,6-dienol, while Egyptian-origin samples showed markers including (E,E)-hepta-2,4-dienal, hexanoic acid, limonene, tridecane, and eugenol. Odor-active markers also differed by origin, confirming that violet absolute is both chemically and sensorially origin-sensitive.
A 2016 metabolomics authentication study pushed this further by applying nontargeted UHPLC-ToFMS to violet leaf absolutes. The study found significant differences in metabolic fingerprints according to geographic origin and/or adulteration, and concluded that this method could be used to identify raw-material origin and detect possible fraud in high-value violet absolutes. For perfumery and aromatherapy, this is highly relevant: violet is a rare, expensive extract, and authenticity testing is not optional in serious professional work.
The most aromatherapy-relevant compositional paper may be the 2023 study of three commercially available V. odorata oils, analyzed by GC–MS. It found strong inter-supplier variability. One sample contained 2-nonynoic acid, methyl ester (54.3%) as its dominant constituent; another had phenethyl alcohol (39.0%) and isopropyl myristate (42.7%), with the authors noting that the isopropyl myristate suggested possible adulteration; and a third was dominated by α-terpineol (38.51%) and benzyl acetate (17.6%).
The same paper explicitly concluded that there was clear qualitative and quantitative variation across the commercial violet oils tested.
Taken together, these analyses show that the chemistry of Viola odorata in commerce is best understood as variable and matrix-dependent. The broader genus Viola contains roughly 200 identified compounds across nonvolatile and volatile fractions, including flavonoids, coumarins, alkaloids, triterpenoids, saponins, anthocyanins, terpenoids, lignans, sesquiterpenes, cyclotides, and phenylpropanoids; however, many of these belong to plant extracts generally and should not be confused with the volatile profile of violet leaf absolute or aromatic oil.
2. Experimental and bioactivity trials
The 2023 commercial-oil study also evaluated antimicrobial activity using broth microdilution MIC testing and assessed interactions with other essential oils using the fractional inhibitory concentration index (ΣFIC). When tested alone, the violet oils showed overall poor to moderate antimicrobial activity. The most noteworthy stand-alone activity was against Cutibacterium acnes and Candida albicans for two samples, with MIC values in the 0.50–0.67 mg/mL range, while the Turkish sample showed noteworthy activity against Staphylococcus epidermidis.
The same study found that violet performed more interestingly in combination than alone. Across combinations with 20 commercial essential oils, the authors reported 55 synergistic interactions, with the strongest combinations involving Santalum austrocaledonicum, and minimum inhibitory concentrations as low as 0.13 mg/mL. Synergy was seen especially against Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterococcus faecium. For a professional dossier, this supports a cautious conclusion: violet is not strongly validated as a stand-alone antimicrobial aromatic, but it may function as a supportive blending component in multi-oil systems.
3. Human clinical trials
The human clinical evidence for Viola odorata is still relatively small, but there are several published trials. A 2014 pretest-posttest insomnia study treated 50 patients with chronic insomnia using intranasal violet oil drops nightly for one month. The authors reported significant improvement in sleep and Insomnia Severity Index (ISI) scores, with only mild adverse effects and no serious adverse events. Because this was not placebo-controlled, it is best treated as preliminary evidence rather than strong confirmation.
A stronger 2018 three-arm, double-blind randomized trial enrolled 75 patients with chronic insomnia and compared intranasal violet oil, almond oil, and placebo over 30 days. Participants completed PSQI and ISI questionnaires before and after treatment. After intervention, the groups differed significantly on both ISI and PSQI, and the violet-oil group showed the greatest effect, with the authors noting that the benefit appeared stronger for sleep quality than for sleep quantity.
A 2020 pilot randomized double-blind placebo-controlled study evaluated V. odorata syrup as an add-on treatment for insomnia in patients with depression or OCD. It included 40 patients with depression and 43 with OCD, treated for 4 weeks. The intervention group received 5 mL syrup every 12 hours, and the study reported significant improvements in total PSQI scores, as well as improvements in BDI-II and YBOCS scores. This suggests possible sleep-supportive benefit, but it also moves beyond aromatherapy into oral phytomedicine.
A 2020 double-blind randomized placebo-controlled clinical trial also evaluated sweet violet flower oil in adults with allergic rhinitis. The available indexed summary states that the study found significant positive effects on symptoms, but also notes that larger and longer trials are needed before stronger conclusions can be drawn. Because the accessible abstract details are limited, this study should be cited cautiously.
The most useful overview is a 2022 systematic review and meta-analysis of insomnia studies. It included 4 articles with 5 clinical trials and 224 patients. Compared with placebo, Viola extract led to greater improvement in total PSQI, subjective sleep quality, sleep duration, and ISI scores, but not in sleep latency, habitual sleep efficiency, sleep disturbances, or daytime dysfunction. This suggests a signal of benefit for chronic insomnia, while also showing that the clinical effect is selective rather than comprehensive.
4. Professional interpretation for aromatherapy
From a professional aromatherapy perspective, the evidence supports three careful conclusions. First, Viola odorata is chemically unstable across commercial materials, so GC–MS or equivalent supplier documentation is highly desirable before therapeutic or luxury-formulation use. Second, the strongest human evidence currently clusters around insomnia-related preparations, but these studies use traditional violet oil drops or oral syrup, not standard diffuser-style aromatherapy protocols.
Third, the antimicrobial evidence does not support strong claims for violet as a stand-alone anti-infective essential oil, though it may have value in synergistic blends.
For dossier language, the safest professional position is this: Viola odorata should be described as a rare, chemically variable aromatic botanical with notable perfumery value and limited but promising clinical evidence in sleep-related traditional preparations. Any therapeutic claims beyond that should be made conservatively and tied to the specific preparation studied.
Viola odorata for Aromatherapy and Professional Botanical Use1. Chemical analyses
The analytical literature on Viola odorata shows that “violet” is not a chemically uniform aromatic material. Composition varies substantially according to plant part, extraction method, origin, and likely adulteration status. This is especially important in professional aromatherapy, because commercial “violet oil” or “violet leaf” materials should not be assumed to be interchangeable across suppliers.
A 2012 GC–MS study on V. odorata leaves from central Iran, obtained by a hydro-distillation/solvent-extraction approach, identified 25 compounds representing 92.77% of the analyzed oil. In that sample, the dominant constituents were reported as butyl-2-ethylhexylphthalate (30.10%) and 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-2(4H)-benzofuranone (12.03%). This profile differs markedly from later studies, underscoring the instability of the chemical profile across preparations.
A more detailed 2014 study on violet leaf absolutes used HS-SPME GC/MS together with GC-O/MS and found a much broader volatile picture. The authors identified 70 compounds, of which 61 had not previously been reported for this species. They also demonstrated clear geographic variation between French and Egyptian materials. French-origin samples showed markers such as ethyl hexanoate and (2E,6Z)-nona-2,6-dienol, while Egyptian-origin samples showed markers including (E,E)-hepta-2,4-dienal, hexanoic acid, limonene, tridecane, and eugenol. Odor-active markers also differed by origin, confirming that violet absolute is both chemically and sensorially origin-sensitive.
A 2016 metabolomics authentication study pushed this further by applying nontargeted UHPLC-ToFMS to violet leaf absolutes. The study found significant differences in metabolic fingerprints according to geographic origin and/or adulteration, and concluded that this method could be used to identify raw-material origin and detect possible fraud in high-value violet absolutes. For perfumery and aromatherapy, this is highly relevant: violet is a rare, expensive extract, and authenticity testing is not optional in serious professional work.
The most aromatherapy-relevant compositional paper may be the 2023 study of three commercially available V. odorata oils, analyzed by GC–MS. It found strong inter-supplier variability. One sample contained 2-nonynoic acid, methyl ester (54.3%) as its dominant constituent; another had phenethyl alcohol (39.0%) and isopropyl myristate (42.7%), with the authors noting that the isopropyl myristate suggested possible adulteration; and a third was dominated by α-terpineol (38.51%) and benzyl acetate (17.6%).
The same paper explicitly concluded that there was clear qualitative and quantitative variation across the commercial violet oils tested.
Taken together, these analyses show that the chemistry of Viola odorata in commerce is best understood as variable and matrix-dependent. The broader genus Viola contains roughly 200 identified compounds across nonvolatile and volatile fractions, including flavonoids, coumarins, alkaloids, triterpenoids, saponins, anthocyanins, terpenoids, lignans, sesquiterpenes, cyclotides, and phenylpropanoids; however, many of these belong to plant extracts generally and should not be confused with the volatile profile of violet leaf absolute or aromatic oil.
2. Experimental and bioactivity trials
The 2023 commercial-oil study also evaluated antimicrobial activity using broth microdilution MIC testing and assessed interactions with other essential oils using the fractional inhibitory concentration index (ΣFIC). When tested alone, the violet oils showed overall poor to moderate antimicrobial activity. The most noteworthy stand-alone activity was against Cutibacterium acnes and Candida albicans for two samples, with MIC values in the 0.50–0.67 mg/mL range, while the Turkish sample showed noteworthy activity against Staphylococcus epidermidis.
The same study found that violet performed more interestingly in combination than alone. Across combinations with 20 commercial essential oils, the authors reported 55 synergistic interactions, with the strongest combinations involving Santalum austrocaledonicum, and minimum inhibitory concentrations as low as 0.13 mg/mL. Synergy was seen especially against Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterococcus faecium. For a professional dossier, this supports a cautious conclusion: violet is not strongly validated as a stand-alone antimicrobial aromatic, but it may function as a supportive blending component in multi-oil systems.
3. Human clinical trials
The human clinical evidence for Viola odorata is still relatively small, but there are several published trials. A 2014 pretest-posttest insomnia study treated 50 patients with chronic insomnia using intranasal violet oil drops nightly for one month. The authors reported significant improvement in sleep and Insomnia Severity Index (ISI) scores, with only mild adverse effects and no serious adverse events. Because this was not placebo-controlled, it is best treated as preliminary evidence rather than strong confirmation.
A stronger 2018 three-arm, double-blind randomized trial enrolled 75 patients with chronic insomnia and compared intranasal violet oil, almond oil, and placebo over 30 days. Participants completed PSQI and ISI questionnaires before and after treatment. After intervention, the groups differed significantly on both ISI and PSQI, and the violet-oil group showed the greatest effect, with the authors noting that the benefit appeared stronger for sleep quality than for sleep quantity.
A 2020 pilot randomized double-blind placebo-controlled study evaluated V. odorata syrup as an add-on treatment for insomnia in patients with depression or OCD. It included 40 patients with depression and 43 with OCD, treated for 4 weeks. The intervention group received 5 mL syrup every 12 hours, and the study reported significant improvements in total PSQI scores, as well as improvements in BDI-II and YBOCS scores. This suggests possible sleep-supportive benefit, but it also moves beyond aromatherapy into oral phytomedicine.
A 2020 double-blind randomized placebo-controlled clinical trial also evaluated sweet violet flower oil in adults with allergic rhinitis. The available indexed summary states that the study found significant positive effects on symptoms, but also notes that larger and longer trials are needed before stronger conclusions can be drawn. Because the accessible abstract details are limited, this study should be cited cautiously.
The most useful overview is a 2022 systematic review and meta-analysis of insomnia studies. It included 4 articles with 5 clinical trials and 224 patients. Compared with placebo, Viola extract led to greater improvement in total PSQI, subjective sleep quality, sleep duration, and ISI scores, but not in sleep latency, habitual sleep efficiency, sleep disturbances, or daytime dysfunction. This suggests a signal of benefit for chronic insomnia, while also showing that the clinical effect is selective rather than comprehensive.
4. Professional interpretation for aromatherapy
From a professional aromatherapy perspective, the evidence supports three careful conclusions. First, Viola odorata is chemically unstable across commercial materials, so GC–MS or equivalent supplier documentation is highly desirable before therapeutic or luxury-formulation use. Second, the strongest human evidence currently clusters around insomnia-related preparations, but these studies use traditional violet oil drops or oral syrup, not standard diffuser-style aromatherapy protocols.
Third, the antimicrobial evidence does not support strong claims for violet as a stand-alone anti-infective essential oil, though it may have value in synergistic blends.
For dossier language, the safest professional position is this: Viola odorata should be described as a rare, chemically variable aromatic botanical with notable perfumery value and limited but promising clinical evidence in sleep-related traditional preparations. Any therapeutic claims beyond that should be made conservatively and tied to the specific preparation studied.